// App-Quantinova.ai

PB0417 : Tissue Factor Pathway Inhibitor Is Increased in Plasma of Patients with a mild to Moderate Bleeding Tendency Independent of Known Genetic Variations in the factor V Encoding Gene

Researchers

Presenter

  • D. Mehic

Principal Investigators

  • A. Tolios

  • S. Hofer

  • H. Haslacher

  • J. Rejt

  • C. Ay

  • M. Haimel

  • I. Pabinger

  • W. Ouwehand

  • K. Downes

  • J. Gebhart

Medical Centers

  • Medical University of Vienna, Medicine I, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

  • Medical University of Vienna, University Clinic for Blood Group Serology and Transfusion Medicine, Vienna, Austria

  • Medical University of Vienna, Department of Laboratory Medicine, Vienna, Austria

  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  • University of Cambridge, Department of Oncology, Cambridge, United Kingdom

Locations

  • Austria

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Tissue factor pathway inhibitor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved